Vanda Pharmaceuticals Reports $22.6M Third-Quarter Loss
Story updates
08:01:26 PM UTC
SquawkNews
Vanda Pharmaceuticals 3Q Loss/Shr 37c >VNDA
08:02:48 PM UTC
SquawkNews
Vanda reported Q3 2026 net loss of $22.6M (diluted loss/share $0.37), flat vs Q3 2025 and improved from Q2 2026. The company updated 2026 revenue guidance to greater than $240M.Material DetailsContext by AI AnalystThis is mid-cycle confirmation of improving revenue momentum and expense control whil…
08:07:58 PM UTC
SquawkNews
Vanda Pharmaceuticals Q3 2026 net loss narrows 64% from Q2 to $22.6 million; Q3 2026 total revenues